Reddit Posts
Quantum stock under the radar
Mentions
I'm still bagholding QTEX :/
My AI Slop Analysis: **\[QTEX\]** Deep Dive #2 β HARD AVOID The first dive called it at $1.61 when the internet was screaming mini-GME. The stock has since bled another 45% to $0.881, and every mechanism that was going to drive it lower has now clicked visibly into place like a machine designed by someone who specifically hates your portfolio. Here is what you are actually looking at. A failed Israeli life-support device company that spent four years proving it could not sell its product, filed thirteen separate equity raises since its 2021 IPO to keep the lights on anyway, and then in May 2026 put on a quantum computing costume and ran headlong into retail Twitter. The costume worked for about three weeks. The stock went from $0.37 to $3.85 and then physics reasserted itself, giving back 77% off the peak. The officers sold $371K worth of shares into that pump β the CFO and COO cashing out between May 27 and June 1 at prices ranging up to $3.51. Not a single one of them has spent a personal dollar buying shares at the current $0.881 where, by the company's own quantum-narrative logic, the opportunity has only gotten more attractively priced. Funny how that works. Zero open-market cash purchases in the past year against eight insider sells, and the most recent insider activity is another 550,000-share grant issued to an officer who already paid himself $321K worth of stock at the $3.37 peak. The people who know every line of this company's books have had months to buy at prices 75% lower than where they sold, and none of them have pressed the fucking button. Before you think about touching this on the dip, understand what's on the calendar. Twelve days out β August 6 β is earnings, the first look at whether any of the commercial momentum announcements translated into actual recognized revenue. The company has now disclosed three separate commercial transactions and every single one of them came with a disclosed dollar amount of zero, nothing, absolute zip. The CEO did promise that revenue would exceed the most recently reported annual revenues of certain publicly traded quantum computing companies, which is a sentence you can make true with a $5,000 purchase order since some early-stage quantum hardware names reported under $500K in their first year. The current TTM is $289K against a $49 million market cap. If August 6 prints a genuine surprise, the thesis cracks. If it prints another quarter of sub-$100K, you have your answer. Any position into that date is a pure event trade β size it like the coin flip it is, not like a thesis. Thirty-four days out is the Annual General Meeting on August 28. Most of the agenda is insider-pay theater: raises for the CEO, RSU grants to the Chairman, director fee bumps across the board. The load-bearing item is a proposal to increase authorized share capital. They already have 55.7 million shares outstanding and enough warrants and grants outstanding to push the fully diluted count to 77.9 million β a 40% dilution overhang sitting above the float right now. They need more authorized shares to keep the machine running. This is not a growth company raising capital for an acquisition. This is a company asking shareholders to vote on the next batch of paper before the current batch finishes printing. On July 21, the company filed to register 6.79 million additional shares β Armistice Capital's warrants from the February 2026 private placement, exercisable at $0.70. Those are already in the money at $0.881, which means Armistice can convert and flood the market at any moment they choose. On the same day they filed yet another employee stock plan registration β their fifth or sixth such filing, because you can apparently never have too many grant spigots aimed at your existing shareholders. The one genuinely clean piece of capital structure news: the 1.64 million IPO Warrants at $5.50 expired worthless on July 15. That is the complete list of positive developments. The new board member, Dr. Shlomit Chappel-Ram, is the real deal β formerly VP R&D at Nano Dimension with hands-on AME hardware experience and peer-reviewed IEEE publications. She is the most substantively credible addition since the rebrand. She is also exactly one board seat inside a structure built around serial dilution and a management team that has put zero personal cash into the stock at these prices. The situation that did not exist at the prior dive has now arrived: three consecutive closes below Nasdaq's $1.00 minimum bid threshold β $0.906, $0.886, and $0.881 on July 22-24. The rule requires thirty consecutive closes before a formal deficiency notice lands. The company already burned through a prior 180-day cure window before the May-June pump rescued it. This time the pump already ran, already failed, and the retail crowd has gone completely silent. The cure options β stock recovers, reverse split, or another equity offering β are all bad for anyone holding at current prices. The AGM to approve more authorized shares falls about a week after the rough end of the recovery window, right around when the deficiency notice could be arriving. Revenue is $289K TTM, dilution is structural and accelerating, insiders treat it like something to sell, not accumulate. **Scalp:** August 6 earnings is the one real event trade in the window. If the commercial order dollar amounts get disclosed and surprise upside, you get a pop worth playing with a hard floor below $0.75. Sized like the binary it is. **Short:** Structurally correct, tactically difficult β borrow is expensive and a single unnamed-partner press release can spike this 40% intraday before you can adjust.
QTEX. Unrecognized serious contributor to quantum data center build out. Low float with insider concentration ready to let it run after holding it down to load up.